Cargando…
Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera
Up to 20% of patients with polycythemia vera have karyotypic abnormalities at the time of the initial diagnosis. However, the cytogenetic abnormalities in polycythemia vera have not been well characterized and their prognostic impact is largely unknown. In this study, we aimed to address these issue...
Autores principales: | Tang, Guilin, Hidalgo Lopez, Juliana E., Wang, Sa A., Hu, Shimin, Ma, Junsheng, Pierce, Sherry, Zuo, Wenli, Carballo-Zarate, Adrian Alejandro, Yin, C. Cameron, Tang, Zhenya, Li, Shaoying, Medeiros, L. Jeffrey, Verstovsek, Srdan, Bueso-Ramos, Carlos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685217/ https://www.ncbi.nlm.nih.gov/pubmed/28473622 http://dx.doi.org/10.3324/haematol.2017.165795 |
Ejemplares similares
-
Updates in the management of polycythemia vera and essential thrombocythemia
por: Bose, Prithviraj, et al.
Publicado: (2019) -
Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
por: Bryan, Jeffrey C., et al.
Publicado: (2016) -
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
por: Vaddi, Kris, et al.
Publicado: (2016) -
Is hyperdiploidy a favorable cytogenetics in adults with B‐lymphoblastic leukemia?
por: Chen, Zhining, et al.
Publicado: (2019) -
Real-world treatments and thrombotic events in polycythemia vera patients in the USA
por: Verstovsek, Srdan, et al.
Publicado: (2023)